Inhibition of neuronal nitric oxide synthase activity does not alter vasopressin secretion in septic rats.

Abstract:

BACKGROUND/PURPOSE:During the early phase of sepsis, hypotension is accompanied by increase of plasma vasopressin hormone (AVP) levels, which decline during the late phase. This hypotension is due in part to increase of nitric oxide (NO) synthesis by nitric oxide synthase (NOS) enzyme. Neuronal isoform of this enzyme (nNOS) is present in vasopressinergics neurons of hypothalamus, but its role in vasopressin secretion during sepsis is unknown. METHODS:We evaluated the role of nNOS in NO production and vasopressin secretion during sepsis. Wistar rats received 7-nitroindazole (50 mg/kg, i.p.), an inhibitor of nNOS activity, or vehicle and were submitted to septic stimulus by cecal ligation and puncture (CLP). At the time points 0, 4, 6, 18 and 24 h after sepsis induction the animals were decapitated and neurohypophysis and hypothalamus were removed for analysis of vasopressin content and NOS activity, respectively. Hematocrit, serum sodium, osmolality, proteins and plasmatic AVP were quantified. RESULTS:Mortality was not affected by 7-nitroindazole (7-NI). Sodium and plasma proteins levels decreased after CLP and the treatment anticipated the protein loss, and delayed serum sodium decrease. Septic animals treated with 7-NI showed decrease of osmolality 4 h after CLP. Nitric oxide synthase activity in hypothalamus increased at 4 and 24 h after CLP and was reduced with 7-NI. Neurohypophysis content of AVP diminished after CLP and 7-NI did not alter this parameter. Plasma AVP levels increased at 6 h and decreased 18 and 24 h after CLP. Treatment with 7-NI did not alter plasma vasopressin levels. CONCLUSION:We concluded that nNOS does not have a substantial role in vasopressin secretion during experimental sepsis.

journal_name

Pituitary

journal_title

Pituitary

authors

Coelho CH,Martins TF,Oliveira-Pelegrin GR,da Rocha MJA

doi

10.1007/s11102-017-0786-x

subject

Has Abstract

pub_date

2017-06-01 00:00:00

pages

333-339

issue

3

eissn

1386-341X

issn

1573-7403

pii

10.1007/s11102-017-0786-x

journal_volume

20

pub_type

杂志文章
  • A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred.

    abstract::Familial neurohypophyseal diabetes insipidus (FNDI) is mostly an autosomal dominant inherited disorder presenting with severe polydipsia and polyuria typically in early childhood. To date, 69 different variations in the AVP gene encoding the AVP prohormone have been identified in autosomal dominant FNDI (adFNDI). In t...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0392-x

    authors: Birkegaard C,Christensen JH,Falorni A,Marzotti S,Minarelli V,Gregersen N,Rittig S

    更新日期:2013-06-01 00:00:00

  • Silent somatotroph pituitary adenomas: an update.

    abstract::Silent growth hormone adenomas (SGHA) are a rare entity of non-functioning pituitary neuroendocrine tumors. Diagnosis is invariably made post-operatively of a tumor immunopositive for GH (and Pit-1 in selected cases) but without clinical acromegaly. Mainly young females are affected, and tumors are often uncovered by ...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-017-0858-y

    authors: Langlois F,Woltjer R,Cetas JS,Fleseriu M

    更新日期:2018-04-01 00:00:00

  • Pituitary lymphoma: a case report and literature review.

    abstract::We report the case of a B-cell type pituitary lymphoma in a 65 year-old male immunocompetent patient who presented with hypogonadotropic hypogonadism and central hypothyroidism and subsequently developed pulmonary lymphoma. Only three cases of pituitary lymphoma have been previously reported, one in a patient with acq...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1009969417380

    authors: Mathiasen RA,Jarrahy R,Cha ST,Kovacs K,Herman VS,Ginsberg E,Shahinian HK

    更新日期:2000-05-01 00:00:00

  • Clinical picture and the treatment of TBI-induced hypopituitarism.

    abstract::Traumatic brain injury (TBI) is an important public health problem with an increasing incidence in the last years. Relatively few cases are fatal; most individuals will survive and, in the long-term, the sequalae of TBI will include neuroendocrine dysfunctions with a much higher frequency than previously suspected. Pa...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-019-00956-w

    authors: Caputo M,Mele C,Prodam F,Marzullo P,Aimaretti G

    更新日期:2019-06-01 00:00:00

  • A case of lymphocytic infundibuloneurohypophysitis: histophathological studies.

    abstract::A 57-year-old woman presented with 2-year history of polyuria and polydipsia. Hormonal studies revealed almost normal anterior pituitary function and central diabetes insipidus. Magnetic resonance imaging showed thickening of the pituitary stalk and enlargement of the neurohypophysis without high intensity of the post...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1009914711287

    authors: Waki K,Yamada S,Ozawa Y,Seki K,Endo Y

    更新日期:1999-05-01 00:00:00

  • Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.

    abstract::We report the case of a 60 year old male who complained of headache and blurry vision--that progressed to left ophthalmoplegia and ptosis--after receiving a dose of leuprolide for Prostate cancer therapy. Imaging showed a hemorrhagic sellar mass. The patient underwent transsphenoidal debulking, and the tissue obtained...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-009-0202-2

    authors: Guerra Y,Lacuesta E,Marquez F,Raksin PB,Utset M,Fogelfeld L

    更新日期:2010-01-01 00:00:00

  • Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.

    abstract::Postoperative serum cortisol is used as an indicator of Cushing's disease (CD) remission following transsphenoidal surgery (TSS) and guides (controversially) the need for immediate adjuvant treatment for CD. We investigated postoperative cortisol and adrenocorticotropic hormone (ACTH) levels as predictors of remission...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0455-z

    authors: Hameed N,Yedinak CG,Brzana J,Gultekin SH,Coppa ND,Dogan A,Delashaw JB,Fleseriu M

    更新日期:2013-12-01 00:00:00

  • Geometric survey on magnetic resonance imaging of growth hormone producing pituitary adenoma.

    abstract::Apart from the radiologic features regarding size and invasiveness, we had noticed some differences in morphology among types of pituitary adenomas. We conducted this study to verify the differences in radiologic morphology between growth hormone producing pituitary adenomas (GHoma) and nonfunctioning pituitary adenom...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0479-z

    authors: Bakhtiar Y,Hanaya R,Tokimura H,Hirano H,Oyoshi T,Fujio S,Bohara M,Arita K

    更新日期:2014-04-01 00:00:00

  • Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?

    abstract::Cushing's Syndrome (CS) is associated with an increased mortality, where hypercoagulability seems to have a crucial role in both arterial and venous thrombosis. Parameters of in vitro thrombin generation (TG) such as lag time, peak thrombin and endogenous thrombin potential (ETP), that describe the time until thrombin...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0467-3

    authors: Koutroumpi S,Spiezia L,Albiger N,Barbot M,Bon M,Maggiolo S,Gavasso S,Simioni P,Frigo A,Mantero F,Scaroni C

    更新日期:2014-02-01 00:00:00

  • Inferior petrosal sinus ACTH and prolactin responses to CRH in ACTH-dependent Cushing's syndrome: a single centre experience from the United Kingdom.

    abstract::Inferior petrosal sinus sampling (IPSS) of ACTH with CRH stimulation helps distinguish pituitary ACTH-dependent Cushing's syndrome from the ectopic ACTH syndrome (EAS). The usefulness of the paradoxical response of other pituitary hormones including prolactin to CRH remains controversial. Data from 33 IPSS procedures ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-009-0200-4

    authors: Daousi C,Nixon T,Javadpour M,Hayden K,MacFarlane IA

    更新日期:2010-06-01 00:00:00

  • Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center.

    abstract:PURPOSE:Long-acting somatostatin analogs are one of the main classes of medical therapy used for acromegaly and most patients require ongoing treatment. Few studies have evaluated the long-term efficacy and safety of lanreotide depot beyond 2 years. The goal of this study was to provide a long-term longitudinal assessm...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-016-0724-3

    authors: Sagvand BT,Khairi S,Haghshenas A,Swearingen B,Tritos NA,Miller KK,Klibanski A,Nachtigall LB

    更新日期:2016-08-01 00:00:00

  • Combined treatment of invasive giant prolactinomas.

    abstract::The management of invasive giant prolactinomas (IGP) has been an area of some controversy. The relative roles of transsphenoidal surgery, craniotomy, radiation therapy and dopamine agonist based medical therapy are gradually becoming clarified. We report the results of management of 30 patients with IGP. Surgery was t...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-005-5087-0

    authors: Yu C,Wu Z,Gong J

    更新日期:2005-01-01 00:00:00

  • The genetic background of acromegaly.

    abstract::Acromegaly is caused by a somatotropinoma in the vast majority of the cases. These are monoclonal tumors that can occur sporadically or rarely in a familial setting. In the last few years, novel familial syndromes have been described and recent studies explored the landscape of somatic mutations in sporadic somatotrop...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-017-0789-7

    authors: Gadelha MR,Kasuki L,Korbonits M

    更新日期:2017-02-01 00:00:00

  • Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging.

    abstract::The availability of various first-line treatment modalities for acromegaly and evolving surgical techniques emphasize the need for accurately defined predictors of surgical outcome. We retrospectively analysed the outcome of 30 patients with acromegaly after initial endoscopic transsphenoidal surgery in two university...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0395-7

    authors: van Bunderen CC,van Varsseveld NC,Baayen JC,van Furth WR,Aliaga ES,Hazewinkel MJ,Majoie CB,Freling NJ,Lips P,Fliers E,Bisschop PH,Drent ML

    更新日期:2013-06-01 00:00:00

  • MAP-2 expression in the human adenohypophysis and in pituitary adenomas. An immunohistochemical study.

    abstract::MAP-2, a well characterized member of the microtubule associated protein (MAP) family, binds to and stabilizes microtubules and is involved in cell proliferation as well as neuronal differentiation. The aim of the present work was to study MAP-2 expression in human adenohypophyses and pituitary adenomas. To our knowle...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-005-1523-4

    authors: Rotondo F,Oniya K,Kovacs K,Bell CD,Scheithauer BW

    更新日期:2005-01-01 00:00:00

  • Sellar collision tumor involving pituitary gonadotroph adenoma and chondroma: a potential clinical diagnosis.

    abstract::We report on a 74-year-old male patient who presented with progressive neuroophthalmologic symptoms soon after the administration of a long-acting gonadotropin-releasing hormone agonist for treatment of a prostate cancer. Imaging revealed a destructively growing and extensively calcified sellar mass inconsistent with ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-009-0199-6

    authors: Sahli R,Christ E,Kuhlen D,Giger O,Vajtai I

    更新日期:2011-12-01 00:00:00

  • Ectopic pituitary adenomas: common presentations of a rare entity.

    abstract:PURPOSE:Ectopic pituitary adenomas (EPA) are rare tumors thought to arise from embryological remnants along the route of normal pituitary migration. Clinically, these tumors vary in hormonal activity and can exert mass effect based on location and size. METHODS:We performed a single-center retrospective analysis of pa...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-019-00954-y

    authors: Agely A,Okromelidze L,Vilanilam GK,Chaichana KL,Middlebrooks EH,Gupta V

    更新日期:2019-08-01 00:00:00

  • Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

    abstract::Non-functioning pituitary carcinomas (NFPC) are defined as tumours of adenophyseal origin with craniospinal or systemic dissemination, with the absence of a hormonal hypersecretion syndrome. These are a histologically heterogenous group of tumours, comprising gonadotroph, null cell, "silent" tumours of corticotroph, s...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-017-0857-z

    authors: Lenders N,McCormack A

    更新日期:2018-04-01 00:00:00

  • The effect of somatostatin analogs and acromegaly on the upper gastrointestinal system.

    abstract:PURPOSE:To evaluate the effects of somatostatin analogs and disease activity status on the upper gastrointestinal system in patients with acromegaly. METHODS:One hundred eighty-one patients with acromegaly were retrospectively assessed. The demographic, biochemical, pathologic, and radiologic data of the patients were...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-020-01095-3

    authors: Sahin S,Icli TB,Durcan E,Sulu C,Ozkaya HM,Hatemi AI,Kadioglu P

    更新日期:2020-10-19 00:00:00

  • Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline.

    abstract:OBJECTIVE:The purpose of this study was to define safety and efficacy of medical therapy in the treatment of nonfunctioning pituitary tumours. DESIGN:We studied thirteen patients with a clinically nonfunctioning pituitary macroadenoma for response to cabergoline treatment for 1 year. Twelve/13 patients were already op...

    journal_title:Pituitary

    pub_type: 临床试验,杂志文章

    doi:10.1023/a:1015366923810

    authors: Lohmann T,Trantakis C,Biesold M,Prothmann S,Guenzel S,Schober R,Paschke R

    更新日期:2001-08-01 00:00:00

  • Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.

    abstract::Lanreotide depot (LD; commercial name Somatuline(®) Depot) is an injectable, extended-release formulation of the synthetic somatostatin analog (SSA) lanreotide. In recent clinical trials, LD was found to be suitable for self or partner administration, avoiding the need to travel to a medical facility. The Somatuline(®...

    journal_title:Pituitary

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s11102-012-0460-2

    authors: Salvatori R,Woodmansee WW,Molitch M,Gordon MB,Lomax KG

    更新日期:2014-02-01 00:00:00

  • GH deficiency in cancer survivors in the transition age: diagnosis and therapy.

    abstract:BACKGROUND:Survival rates among childhood cancer survivors (CCSs) have significantly risen in the last 40 years due to substantial improvements in treatment protocols. However, this improvement has brought with it serious late effects that frequently involve the endocrine system. Of the endocrine disorders, GH deficien...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-020-01052-0

    authors: Sbardella E,Crocco M,Feola T,Papa F,Puliani G,Gianfrilli D,Isidori AM,Grossman AB

    更新日期:2020-08-01 00:00:00

  • Be careful... She has a pituitary gland in her nose.

    abstract::In this case report we describe a 38 year-old-female with galactorrhea several months after the birth of an anencephalic child. She had hyperpolactemia and imaging of the pituitary gland revealed a midline defect and a nasopharyngeal mass compatible with a meningo-(hypophyso-) encephalocele and possibly an ectopic ter...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-011-0320-5

    authors: Rabelink NM,Lips P,Castelijns JA

    更新日期:2012-12-01 00:00:00

  • Leptin and the pituitary.

    abstract::Although leptin was originally viewed as an antiobesity hormone, it is now evident that it may have more pleiotropic actions. Experiments in rodents have shown that leptin activates the sympathetic nervous system, is involved in regulation of blood pressure, hematopoiesis, immune function, angiogenesis and brain, bone...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1012938308654

    authors: Popovic V,Damjanovic S,Dieguez C,Casanueva FF

    更新日期:2001-01-01 00:00:00

  • Decreased insulin requirements after LAR-octreotide but not after lanreotide in an acromegalic patient.

    abstract::A diabetic acromegalic man, not cured after surgery and radiosurgery, received lanreotide i.m. with great clinical and biochemical improvement. He required NPH insulin (76 to 84 units/day) to control his diabetes mellitus. Thirty-six hours after changing to LAR-octreotide (20 mg i.m/month) he presented symptomatic hyp...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1020710800842

    authors: Webb SM,Ortega E,Rodríguez-Espinosa J,Mato ME,Corcoy R

    更新日期:2001-09-01 00:00:00

  • Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.

    abstract::A high incidence of venous thromboembolic (VTE) complications has been reported in Cushing's syndrome (CS), mostly post-operatively and attributable to hypercoagulability. The prevalence of symptomatic VTE was investigated retrospectively in 58 consecutive CS patients in relation to acquired and genetic thrombotic ris...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0398-4

    authors: Koutroumpi S,Daidone V,Sartori MT,Cattini MG,Albiger NM,Occhi G,Ferasin S,Frigo A,Mantero F,Casonato A,Scaroni C

    更新日期:2013-06-01 00:00:00

  • Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses.

    abstract::The molecular pathogenesis of prolactinomas has resisted elucidation; with the exception of a RAS mutation in a single aggressive prolactinoma, no mutational changes have been identified. In prolactinomas, a further obstacle has been the paucity of surgical specimens suitable for molecular analysis since prolactionoma...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-007-0082-2

    authors: Evans CO,Moreno CS,Zhan X,McCabe MT,Vertino PM,Desiderio DM,Oyesiku NM

    更新日期:2008-01-01 00:00:00

  • Medical management of pituitary adenomas: structural and ultrastructural changes.

    abstract::The morphology of the various pituitary cell types is highly dynamic and allows recognition of many cellular functions. Most pituitary cells show morphologic changes that reflect stimulation or inhibition by hormones. Drugs have also been shown to alter the morphology of several pituitary tumor types, allowing a measu...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1022320732718

    authors: Asa SL,Ezzat S

    更新日期:2002-01-01 00:00:00

  • Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes.

    abstract:BACKGROUND:Xanthogranulomas are inflammatory masses most commonly found at peripheral sites such as the skin. Sellar and parasellar xanthogranulomas are rare and present a diagnostic challenge as they are difficult to differentiate from other sellar lesions such as craniopharyngiomas and Rathke's cleft cysts pre-operat...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-017-0859-x

    authors: Ved R,Logier N,Leach P,Davies JS,Hayhurst C

    更新日期:2018-06-01 00:00:00

  • Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis.

    abstract:PURPOSE:Hypophysitis develops in up to 19% of melanoma patients treated with ipilimumab, a cytotoxic T-lymphocyte antigen-4 antibody. Early detection may avert life-threatening hypopituitarism. We aimed to assess the incidence of ipilimumab-induced hypophysitis (IH) at a quaternary melanoma referral centre, and to dete...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-018-0866-6

    authors: De Sousa SMC,Sheriff N,Tran CH,Menzies AM,Tsang VHM,Long GV,Tonks KTT

    更新日期:2018-06-01 00:00:00